FDG-PET evaluation of therapeutic effects on VX2 liver tumor

Journal of Nuclear Medicine

Volumn 37, Issue 2, 1996, Pages 296-302

  Oya, Natsuo ^a,b   Nagata, Yasushi ^a   Tamaki, Nagara ^a   Takagi, Takehisa ^a   Murata, Rumi ^a   Magata, Yasuhiro ^a   Abe, Mitsuyuki ^a   Konishi, Junji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

fluorine 18 fluorodeoxyglucose; radiotherapy; transcatheter arterial embolization; VX2 tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GELATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; ELECTRON THERAPY; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT;

ANIMALS; DEOXYGLUCOSE; EMBOLIZATION, THERAPEUTIC; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GELATIN SPONGE, ABSORBABLE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NEOPLASM TRANSPLANTATION; RABBITS; RADIOTHERAPY, HIGH-ENERGY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029921427     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 18F): nontoxic tracer for rapid tumor detection. J Nucl Med 1980;21:670-675.
2. 18F-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection. Eur J Nucl Med 1982;7:294-297.
3. 18FDG differential diagnosis of inflammation from malignant tumor. Kaku Igaku 1983,20:1189-1192.
4. 18F-2-fluoro-2-deoxy-D-glucose: imaging of rabbit VX2 tumor with single photon gamma gamera Kaku Igaku 1985,22:389-391
5. Oya N, Nagata Y, Ishigaki T, et al. Evaluation of experimental liver tumors using fluorine-18-2-fluoro-2-deoxy-D-glucose PET J Nucl Med 1993;34 2124-2129.
6. 18F-fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982,23. 1133-1137.
7. Messa C, Choi Y, Hoh CK, et al. Quantification of glucose utilization in liver metastases parametric imaging of FDG uptake with PET. J Comput Assist Tomogr 1992,16:684-689.
8. Kubota K, Matsuzawa T, Fujiwara T, et al Differential diagnosis of lung tumor with positron emission tomography a prospective study. J Nucl Med 1990,31.1927-1932.
9. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332
10. Minn H, Aitasalo K, Happonen RP. Detection of cancer recurrence in irradiated mandible using positron emission tomography Eur Arch Otorhinolaryngol 1993;250: 312-315
11. 18F] fluorodeoxyglucose in brain tumors, a powerful diagnostic and prognostic tool Invest Radiol 1987;22 360-371.
12. Okazumi S, Isono K, Enomoto K, et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment J Nucl Med 1992;33:333-339.
13. Hawkins RA, Choi Y, Huang S-C, Messa C, Hoh CK, Phelps ME. Quantitating tumor glucose metabolism with FDG and PET. J Nucl Med 1992;33.339-344.
14. Haberkorn U, Strauss LG, Reisser CH, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors, relation of positron emission tomography to flow cytometry J Nucl Med 1991;32:1548-1555.
15. Hawkins RA, Hoh C, Dahlborn M, et al PET cancer evaluations with FDG. J Nucl Med 1991;32:1555-1558.
16. Rege S, Maass A, Chaiken L, et al. Use of positron omission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-3058.
17. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fluorodeoxyglucose J Nucl Med 1988;29:1521-1525.
18. 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990,19:1005-1010.
19. Haberkorn U, Strauss LG, Dimitrakopoulou A, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485-1490
20. Okada J, Oonishi H, Yoshikawa K, et al FDG-PET for the evaluation of tumor viability after anticancer therapy. Ann Nucl Med 1994;8 109-113
21. Mogard J, Kihlström L, Ericson K, Karlsson B, Guo WY, Stone-Elander S. Recurrent tumor versus radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG. J Comput Assist Tomogr 1994;18:177-181.
22. Rege SD, Chaiken L, Hoh CK, et al Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET Radiology 1993,189:807-812.
23. 18F-FDG positron emission tomography J Comput Assist Tomogr 1990;14:370-374.
24. 18F-2-fluoro-2-deoxy-D-glucose. Eur J Nucl Med 1986,12: 325-328.
25. 3H] thymidine, and gallium-67. J Nucl Med 1991;32:2118-2123.
26. 3H] deoxyglucose in the tumor model, following chemotherapy and radiotherapy. J Nucl Med 1985;26.278-282
27. 14C]-glucose during chemotherapy in murine Lewis lung tumor. Nucl Med Biol 1992;19:55-63
28. Hase M, Sako M, Hirota S. Experimental study of ferromagnetic induction heating combined with hepatic arterial embolization for treatment of liver tumors Nippon Act Radiol 1990;50:1402-1414.
29. 18F-labeled acetyl hypofluorite J Nucl Med 1982;23.899-903.
30. Mitsumori M, Hiraoka M, Shibata T, et al. Development of intra-arterial hyperthermia using a dextran-magnetite complex. Int J Hyperthermia 1994;10:785-793.
31. Watanabe M, Uchida H, Okada H, et al A high resolution PET for animal studies IEEE Trans Medical Imaging 1992,11 577-580.
32. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data J Cereb Blood FLow Metab 1983;3:1-7
33. Patlak CS, Blasberg RG Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data generalizations J Cereb Blood Flow Metab 1985 5. 584-590.
34. 18F]fluorodeoxyglucose for monitoring hepatocellular carcinoma after interventional therapy J Nucl Med 1994;35:1965-1969.
35. Rozental JM, Levine RL, Mehta MP, et al Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy. Int J Radiol Oncol Biol Phys 1991,20:1053-1060
36. 18F]FDG distribution within mouse FM3A tumor tissue in vivo. Kaku Igaku 1992,29:1215-1221
37. Kubota K, Matsuzawa T, Takahashi T, et al. Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. J Nucl Med 1989,30:2012-2016.
38. Higashi K, Clavo AC, Wahl RL Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-419.
39. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D-glucose. L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy J Nucl Med 1993,34 773-779
40. Hall EJ Radiobiology for the radiologist, 4th ed. Philadelphia JB Lippincott; 1994